Oak review

Oak: cheap compounded injections, if you read past the headline

Oak advertises compounded semaglutide from $119 a month and tirzepatide from $185, with free health coaching, free shipping, and no separate membership fee — a genuinely low entry point for a household budget. The number that matters, though, is not the one on the landing page. Oak's public funnel shows those "from" figures require a longer multi-month prepay plan; a single-month plan was observed closer to $235 and $285 for the two molecules. Price the month-to-month rate honestly before assuming the headline is what you'll pay.

Async care, and no refunds once medication ships

Oak's intake is fully asynchronous with no required video visit — a real convenience for a mother avoiding scheduled camera appointments. The tradeoff sits in the Terms: no refunds once medication ships, and binding arbitration for disputes. For anyone prepaying a multi-month plan to reach the lower rate, that no-refund clause is worth weighing against the savings before committing.

• Semaglutide: $235/mo single-month, from $119/mo on a longer prepay plan
• Tirzepatide: $285/mo single-month, from $185/mo on a longer prepay plan
• Included: free health coaching and free shipping, no membership fee
• Not included: a video visit (none required), a refund once medication ships

The trust caveats worth knowing before you prepay

A few things are missing from Oak's public materials that a more established competitor typically discloses: its compounding pharmacies are not named anywhere, and its founder is undisclosed. Its BBB-listed address (Vancouver, BC) also does not match its Delaware corporate filing, and its Trustpilot history is thin — around 46 reviews. None of that is a safety finding on its own, but for a mother who wants a named pharmacy and a clean paper trail before prepaying several months, they are reasons to look closely.

A genuine low-dose option, done the right way

One thing Oak gets right: it sells a formulated, clinician-set low-dose tier rather than leaving dose math to the patient measuring her own draw from a vial — the safer version of the microdosing idea. See our microdosing guide for mothers for why that distinction matters; the FDA has flagged dosing errors, some leading to hospitalization, tied specifically to patients self-measuring from multi-dose vials.

Who this actually suits

Oak is a reasonable fit for a mother whose deciding factor is the monthly number, who is comfortable with an async-only relationship rather than recurring clinician check-ins, and who plans to stay on treatment long enough to make a multi-month prepay worthwhile. It is a weaker fit for anyone who wants a named pharmacy in writing before the first shipment, or who values a company with a longer public track record than roughly 46 Trustpilot reviews.

The bottom line

Oak is a fair budget pick for a mother who reads past the multi-month "from $119" headline, is comfortable with async-only care, and can accept a no-refund-after-shipping policy alongside some real disclosure gaps around its pharmacy and founder. It offers neither postpartum nor PCOS-specific guidance. For a provider built around that maternal framing with equally transparent pricing, our #1 pick, CoreAge Rx, is the stronger fit.